17.1 C
Tuesday, May 24, 2022
-- Free Advertisement --spot_img
HomeCOVID-19Pfizer amends earnings forecasts due to 'Unfavorable Pre-Clinical, Clinical Or Safety Data'

Pfizer amends earnings forecasts due to ‘Unfavorable Pre-Clinical, Clinical Or Safety Data’

Most Popular

Pfizer predicts it will generate a colossal US$54 billion in COVID related earnings in 2022.

However, a number of ‘redline’ changes made to its Q4 2022 earnings releases have analysts believing the company is preparing for some bad news relating to unfavourable pre-clinical, clinical or safety data.

Pfizer earnings news

Pfizer is also now highlighting ‘concerns about clinical data integrity’, and thinks that COVID-19 may, ‘diminish in severity or prevalence, or disappear entirely.’

Read the full report at the Algora Blog.

No login required to comment. Name, email and web site fields are optional. Please remember to keep comments respectful. We believe in free speech. Unfortunately, due the actions of one online troll, we have had to implement a manual moderation system to ensure online discussion remains civil and constructive. Your views and voice are important. Your comment will be published after moderation unless it contains hate speech or defamatory statements.


  1. It is a shame Jacinda Arderns Government signed away our rights to sue Pfizer. I note the victims did not sign anything. Nor did the pro-choice or children. It does not rule out suing the NZ Government for what is now a confirmed unlawful mandate or making an ACC claim. Nor does it excuse Pfizer, its executive officers, staff in the know from criminal intent. A standard set in 1946. Professional negotiation working in parallel with a nationwide class action should be launched.


Please enter your comment!
Please enter your name here


Daily Life

broken clouds
13.7 ° C
14.8 °
13.1 °
79 %
75 %
13 °
14 °
10 °
12 °
14 °
- Free Advertisement -spot_img
- Make Your Voice Heard -spot_img